Correction: liang, j., et Al. Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and e-cadherin. Int. J. Mol. Sci. 2012, 13, 10594-10607

Dong Chen; Yan Wang; Kejun Zhang; Xuelong Jiao; Bomin Yan; Jun Liang

doi:10.3390/ijms14036516

Correction: liang, j., et Al. Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and e-cadherin. Int. J. Mol. Sci. 2012, 13, 10594-10607

Int J Mol Sci. 2013 Mar 22;14(3):6516-7. doi: 10.3390/ijms14036516.

Authors

Dong Chen¹, Yan Wang, Kejun Zhang, Xuelong Jiao, Bomin Yan, Jun Liang

Affiliation

¹ Department of General Surgery, the Affiliated Hospital of Qingdao Medical College, Qingdao University, Qingdao 266003, China. qyfyliang@163.com.

Abstract

The original version of the paper reports that "OGX-011 is a second generation 21-mer oligonucleotide with a 20-O-(2-methoxy)-ethyl modification, generously provided by OncoGenex Technologies (OncoGenex, Vancouver, Canada)" [1] (p. 10602). OGX-011 was not provided by OncoGenex Technologies directly. Therefore, we would like to correct the wording to: "OGX-011 was obtained without the benefit of an agreement with OncoGenex, or The University British Columbia, or any other party". The authors would like to apologize for any inconvenience this may have caused to the readers of this journal.

Publication types

Published Erratum